Know Cancer

or
forgot password

Is There a Role for Using NMR Urine Metabolomics as a New Method of Screening for Colorectal Cancer?


N/A
18 Years
N/A
Open (Enrolling)
Both
Colorectal Cancer, Colorectal Polyps

Thank you

Trial Information

Is There a Role for Using NMR Urine Metabolomics as a New Method of Screening for Colorectal Cancer?


Inclusion Criteria:



For Screening group (normal colonoscopy & colonic polyps):

- asymptomatic, 50-75 year old, without personal or family history of CRC/polyps

- asymptomatic, 40-75 year old, known personal or first-degree family history of
either CRC or polyps

For Cancer group:

- any patient with diagnosis of colorectal cancer

- any patient with diagnosis of prostate cancer

- any patient with diagnosis of breast cancer

Exclusion Criteria:

For screening group:

- hematochezia

- inflammatory bowel disease

- on anticoagulation for reasons other than atrial fibrillation

- significant co-morbidities

For Cancer group:

- already had neoadjuvant treatment at time of urine collection

- no invasive cancer at time of urine collection

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Principal Investigator

Haili Wang, MD FRCS(C)

Investigator Role:

Study Director

Investigator Affiliation:

University of Alberta

Authority:

Canada: Health Canada

Study ID:

MTI-2008

NCT ID:

NCT01486745

Start Date:

April 2008

Completion Date:

June 2013

Related Keywords:

  • Colorectal Cancer
  • Colorectal Polyps
  • Colorectal Neoplasms
  • Colonic Polyps

Name

Location